The AD risk gene FERMT2 also regulates APP whereby silencing or overexpression of FERMT2 results in increased or decreased surface levels of mature APP, respectively, leading to respective changes in secreted amyloid-β [9]. This evidence concerns the gene FERMT2 and Alzheimer disease.